Default welcome msg!
- Home
- About
Company ProfileBadrilla Ltd, founded in 2003, is an established life science company providing high quality products for the molecular cardiovascular researcher located within major pharmaceutical, biotech, and academic establishments worldwide... Read More
Management TeamProfessor Colyer established Badrilla in 2003, combining substantive entrepeneurial experience with a deep understanding of the cardiovascular research field. The company has grown organically, reinvesting revenues into... Read More
- Technology
- The Blog
- Contact
Residue Modification
The post-translational modification of individual residues in a protein is an important feature of protein regulation in health and disease. Highly specific monoclonal antibodies to chemically modified amino acids have been assembled. All of these antibodies have been carefully validated for use in western blotting.
-
Nitrotyrosine mAb (clone 2E11)
$341.30Product code: A010-2E11Affinity purified mouse monoclonal antibody clone 2E11 to nitrotyrosine
- Suitable for use in Western blot (1:2000 dilution)
- Antibody Form: IgG2b
- Protein A affinity purified
- Reacts with Nitrotyrosine either free or incorporated in proteins such as human serum nitro albumin, nitro haemoglobin and nitro insulin. All species
- Unit size: 50 µl
-
Nitrotyrosine mAb (Clone 6B2)
$341.30Product code: A010-6B2APAffinity purified Mouse monoclonal antibody clone 6B2 to NitroTyrosine (NY)
- Suitable for use in Western blot (1:5000 dilution)
- Protein A affinity purified
- Reacts with Nitrotyrosine either free or incorporated in proteins such as human serum nitro albumin, nitro haemoglobin and nitro insulin. All species
- Unit Size: 20 µl
Currently Shopping by:
- Target: Nitrotyrosine Remove This Item
You have no items to compare.
Contact Us
Useful Links
- About Us
- Products
- Citations
- Glossary
- Technical Support
- Placing an Order
- Distributors
- Terms & Conditions
.
DISCLAIMER: Products for research use only (RUO) and are not intended for diagnostic or therapeutic use.
Badrilla Newsletters
